Valerie B. O’Donnell

Dr. Valerie B. O’Donnell


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
GLGerhard Liebisch
Gerhard Liebisch
EFEoin Fahy
Eoin Fahy
JAJunken Aoki
Junken Aoki
EDEdward A. Dennis
Edward A. Dennis
TDThierry Durand
Thierry Durand
FSFriedrich Spener
Friedrich Spener
Gerhard Liebisch, Eoin Fahy, Junken Aoki, Edward A. Dennis, Thierry Durand, Christer S. Ejsing, Maria Fedorova, Ivo Feussner, William J. Griffiths, Harald Köfeler, Alfred H. Merrill Jr., Robert C. Murphy, Valerie B. O’Donnell, Olga Oskolkova, Shankar Subramaniam, Michael J. O. Wakelam, Friedrich Spener

19 October 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MCMatthew J Conroy
Matthew J Conroy
RARobert M Andrews
Robert M Andrews
SASimon Andrews
Simon Andrews
LCLauren Cockayne
Lauren Cockayne
EDEdward A. Dennis
Edward A. Dennis
VOValerie B. O’Donnell
Valerie B. O’Donnell
LIPID MAPS (LIPID Metabolites and Pathways Strategy), www.lipidmaps.org, provides a systematic and standardized approach to organizing lipid structural and biochemical data. Founded 20 years ago, the LIPID MAPS nomenclature and classification has become the accepted community standard. LIPID MAPS provides databases for cataloging and identifying lipids at varying levels of characterization in addition to numerous software tools and educational resources, and became an ELIXIR-UK data resource in 2020. This paper describes the expansion of existing databases in LIPID MAPS, including richer metadata with literature provenance, taxonomic data and improved interoperability to facilitate FAIR compliance. A joint project funded by ELIXIR-UK, in collaboration with WikiPathways, curates and hosts pathway data, and annotates lipids in the context of their biochemical pathways. Updated features of the search infrastructure are described along with implementation of programmatic access via API and SPARQL. New lipid-specific databases have been developed and provision of lipidomics tools to the community has been updated. Training and engagement have been expanded with webinars, podcasts and an online training school.

10 January 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
NANaomi E. Allen
Naomi E. Allen
BLBen Lacey
Ben Lacey
DLDeborah A. Lawlor
Deborah A. Lawlor
JPJill P. Pell
Jill P. Pell
JGJohn Gallacher
John Gallacher
RCRory Collins
Rory Collins
Population-based prospective studies, such as UK Biobank, are valuable for generating and testing hypotheses about the potential causes of human disease. We describe how UK Biobank’s study design, data access policies, and approaches to statistical analysis can help to minimize error and improve the interpretability of research findings, with implications for other population-based prospective studies being established worldwide.

19 January 2001 in Circulation Research
Verified
Journal Article
Closed access
PDF file
VOValerie B. O’Donnell
Valerie B. O’Donnell
BFBruce A. Freeman
Bruce A. Freeman
—Nitric oxide (·NO) signaling pathways and lipid oxidation reactions are of central importance in both the maintenance of vascular homeostasis and the progression of vascular disease. Because both of these pathways involve free radical species that can also react together at extremely fast rates, convergent interactions between these pathways are expected. Biochemical and cell biology studies have defined multiple interactions of·NO with oxidizing lipids that could lead to either vascular protection or potentiation of inflammatory vascular injury. For example, low levels of·NO generated by endothelial nitric oxide synthase can terminate propagating lipid radicals and inhibit lipoxygenases, reactions that would be protective. Alternatively, if generated at elevated levels, for example, after inducible nitric oxide synthase expression in inflammation,·NO can be converted to prooxidant species, such as peroxynitrite (ONOO–) and nitrogen dioxide (·NO2), that can potentiate inflammatory injury to vascular cells. Finally, both enzymatic and nonenzymatic lipid oxidation reactions can influence·NO bioactivity by directly scavenging·NO or altering the induction and catalytic activity of nitric oxide synthase enzymes. In this review, we summarize the biochemical interactions between·NO and lipid oxidation reactions and discuss the recognized and potential roles of these reactions in the vasculature.

1 May 2016 in Cell Metabolism
Verified
Journal Article
Open access
DSDavid A. Slatter
David A. Slatter
MAMaceler Aldrovandi
Maceler Aldrovandi
AOAnne O’cOnnor
Anne O’cOnnor
SAStuart M. Allen
Stuart M. Allen
CBChristopher J. Brasher
Christopher J. Brasher
VOValerie B. O’Donnell
Valerie B. O’Donnell
Human platelets acutely increase mitochondrial energy generation following stimulation. Herein, a lipidomic circuit was uncovered whereby the substrates for this are exclusively provided by cPLA2, including multiple fatty acids and oxidized species that support energy generation via β-oxidation. This indicates that acute lipid membrane remodeling is required to support energetic demands during platelet activation. Phospholipase activity is linked to energy metabolism, revealing cPLA2 as a central regulator of both lipidomics and energy flux. Using a lipidomic approach (LipidArrays), we also estimated the total number of lipids in resting, thrombin-activated, and aspirinized platelets. Significant diversity between genetically unrelated individuals and a wealth of species was revealed. Resting platelets demonstrated ∼5,600 unique species, with only ∼50% being putatively identified. Thrombin elevated ∼900 lipids >2-fold with 86% newly appearing and 45% inhibited by aspirin supplementation, indicating COX-1 is required for major activation-dependent lipidomic fluxes. Many lipids were structurally identified. With ∼50% of the lipids being absent from databases, a major opportunity for mining lipids relevant to human health and disease is presented.

28 March 2014 in Circulation Research
Verified
Journal Article
Closed access
PDF file
VOValerie B. O’Donnell
Valerie B. O’Donnell
RMRobert C. Murphy
Robert C. Murphy
SWStephen P. Watson
Stephen P. Watson
Lipids are diverse families of biomolecules that perform essential structural and signaling roles in platelets. Their formation and metabolism are tightly controlled by enzymes and signal transduction pathways, and their dysregulation leads to significant defects in platelet function and disease. Platelet activation is associated with significant changes to membrane lipids, and formation of diverse bioactive lipids plays essential roles in hemostasis. In recent years, new generation mass spectrometry analysis of lipids (termed lipidomics) has begun to alter our understanding of how these molecules participate in key cellular processes. Although the application of lipidomics to platelet biology is still in its infancy, seminal earlier studies have shaped our knowledge of how lipids regulate key aspects of platelet biology, including aggregation, shape change, coagulation, and degranulation, as well as how lipids generated by platelets influence other cells, such as leukocytes and the vascular wall, and thus how they regulate hemostasis, vascular integrity, and inflammation, as well as contribute to pathologies, including arterial/deep vein thrombosis and atherosclerosis. This review will provide a brief historical perspective on the characterization of lipids in platelets, then an overview of the new generation lipidomic approaches, their recent application to platelet biology, and future perspectives for research in this area. The major platelet-regulatory lipid families, their formation, metabolism, and their role in health and disease, will be summarized.